About QA PharmaPro: Senior Quality & Regulatory Consulting
QA PharmaPro Consulting helps regulated organizations make decisions that can withstand regulatory, customer and business scrutiny.
FOUNDER & SENIOR ADVISOR
Efraín Ghio
More than two decades working across pharmaceutical Quality Control, Quality Assurance, regulated manufacturing and compliance have shaped a practical view: the strongest Quality and Regulatory systems are those that help organizations make better decisions and produce evidence that can withstand scrutiny.
Efraín leads every engagement directly, combining independent senior judgment with hands-on experience in audits, CAPA, investigations, change control, validation, computerized systems and regulated product strategy.
What We Believe
More documentation does not automatically mean more compliance. A defensible Quality or Regulatory decision starts with understanding what must be supported, what the available evidence can actually defend, and where the material risk remains.
That is why we do not begin with templates. We begin with the decision the evidence must support.
Senior-Led, Practical Support
QA PharmaPro is a senior-led consulting practice built around direct expert involvement. Our work draws on more than two decades of experience across pharmaceutical Quality Control, Quality Assurance, regulated manufacturing, audits, CAPA, investigations, change control, validation and computerized systems.
The focus is practical: clarify risk, identify the evidence that matters, prioritize what must change, and support implementation when the business needs more than a report.
Why This Approach
A sensitive Quality or Regulatory decision should not be trusted to a template, an unchecked assumption or advice shaped by the need to sell a larger engagement. It requires independent judgment about what the evidence can support, where the material risk remains and which path can withstand scrutiny.
QA PharmaPro combines direct senior involvement with a risk-based, evidence-first approach. The objective is not to produce more documentation, but to give decision-makers a clear, proportionate and defensible basis for action—even when that means challenging the preferred path.
Where We Work Best
We are most valuable when the business is approaching a consequential milestone: market entry, an FDA or EU regulatory pathway, an audit or inspection, a GxP system implementation, a remediation program, enterprise-customer diligence, or rapid growth.
Typical clients include founders, Quality and Regulatory leaders, product and technology leaders, and sponsors who need an independent senior view before committing the organization to a path that may be expensive to reverse.
How Engagements Are Structured
Written-First
Most engagements can begin asynchronously from a concise brief and the relevant evidence. Calls are used when they materially improve the decision.
Paid Assessment First
We do not turn exploratory conversations into unpaid consulting. The initial assessment is scoped, priced and delivered as a focused piece of senior work.
Senior Direct Delivery
The person framing the decision and reviewing the evidence stays directly involved through the work, including implementation when that is part of the scope.
Independent Assessment Before Commitment
When the next move matters, start by testing whether the current Quality and Regulatory evidence can support it.